Lundbeck launches Northera to treat neurogenic orthostatic hypotension in US
The US Food and Drug Administration (FDA) has recently approved Northera to treat NOH, a disorder caused by an underlying neurologic disease. Currently, the norepinephrine pro-drug Northera is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.